Skip to main content

Table 4 Percentage of change of the studied parameters during the Covid-19 pandemic

From: Glycemic variability and time in range among children with type 1 diabetes on insulin pump during the Covid-19 pandemic in Egypt; single center experience

 

Children with T1DM on insulin pump

No. = 42

BMI

 Median (IQR)

3.53 (1.40–5.14)

 Range

-17.26–11.04

Insulin dose (unit/Kg/day)

 Median (IQR)

0.00 (0.00–14.29)

 Range

-14.29–28.57

Basal %

 Median (IQR)

0.00 (0.00–0.00)

 Range

0.00–33.33

ICR

 Median (IQR)

0.00 (0.00–0.00)

 Range

-20.00–66.67

ISF

 Median (IQR)

0.00 (0.00–0.00)

 Range

-16.67–40.00

 Range

-100.00–250.00

HbA1C (mg/dl)

 Median (IQR)

-10.59 (-22.33–-1.74)

 Range

-44.92–7.14

HbA1C (mmol/mol)

 Median (IQR)

-13.75 (-28.13- -1.96)

 Range

65.12- 10.14

Time above range %

 Median (IQR)

-3.73 (-41.18–38.71)

 Range

-64.71–315.38

Time in range %

 Median (IQR)

12.68 (-6.56–35.71)

 Range

-75.51–284.21

Time above range %

 Median (IQR)

-9.82 (-83.33–120.00)

 Range

-100.00–800.00

Coefficient of variation %

 Median (IQR)

-11.33 (-20.09–6.80)

 Range

-60.34–46.80

  1. BMI Body mass index, ISF Insulin sensitivity factor, ICR Insulin to carbohydrate ratio, DKA Diabetic ketoacidosis, HbA1C Glycatedhaemoglobin, CGMS Continous glucose monitoring system, LDL Low density lipoprotein, HDL High density lipoprotein, UACR Urine albumin creatinine ratio